Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP13 | P45452 | 1/20 | 0.46 |
| ▸ | REN | P00797 | 1/20 | 0.46 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.45 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
| ▸ | ITGA4 | P13612 | 1/20 | 0.43 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.43 |
| ▸ | ACE | P12821 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | CTSS | P25774 | 2/20 | 0.42 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 1/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.41 |
| ▸ | MMP9 | P14780 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL65502 | 1.00 | MMP13 (0.46) | MMP13RENITGB3ITGA2BATM | |
| SCHEMBL1401042 | 1.00 | MMP13 (0.46) | MMP13RENITGB3ITGA2BATM | |
| SCHEMBL30688558 | 0.95 | ITGB3 (0.45) | MMP13RENITGB3ITGA2BATM | |
| SCHEMBL22457743 | 0.95 | ITGB3 (0.45) | MMP13RENITGB3ITGA2BATM | |
| SCHEMBL30688551 | 0.95 | ITGB3 (0.45) | MMP13RENITGB3ITGA2BATM | |
| SCHEMBL1401223 | 0.92 | ALDH1A1 (0.48) | MMP13RENITGB3ITGA2BACE | |
| SCHEMBL28518117 | 0.92 | ALDH1A1 (0.48) | MMP13RENITGB3ITGA2BACE | |
| SCHEMBL29624556 | 0.92 | ALDH1A1 (0.48) | MMP13RENITGB3ITGA2BACE | |
| SCHEMBL18248052 | 0.92 | ALDH1A1 (0.48) | MMP13RENITGB3ITGA2BACE | |
| SCHEMBL8911125 | 0.92 | ALDH1A1 (0.48) | MMP13RENITGB3ITGA2BACE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118007135-A | Corrosion inhibition method for inhibiting metal corrosion in sulfur-containing medium | 福建理工大学 | 2024-05-10 | — | — | CN | claimed |
| CN-109320590-B | Synthetic route to the antibiotic teixobactin and analogues thereof | 清华大学 | 2021-03-02 | — | — | CN | claimed |
| CN-109320590-A | The synthetic route of antibiotic teixobactin and the like | 清华大学 | 2019-02-12 | — | — | CN | claimed |
| CN-103965299-B | A kind of ring pentapeptide and synthetic method thereof and application | 暨南大学 | 2016-07-13 | — | — | CN | claimed |
| CN-103965299-A | Cyclic pentapeptide as well as synthetic method and application thereof | UNIV JINAN | 2014-08-06 | — | — | CN | claimed |
| CN-101274958-A | Bioactive peptide, preparation thereof and application thereof | OCEAN UNIV CHINA (CN) | 2008-10-01 | — | — | CN | claimed |
| US-20250243196-A1 | CITRON KINASE INHIBITORS | THE CLEVELAND CLINIC FOUNDATION | 2025-07-31 | — | — | US | disclosed |
| US-20240262792-A1 | USP30 INHIBITORS AND USES THEREOF | VINCERE BIOSCIENCES, INC. | 2024-08-08 | — | — | US | disclosed |
| CN-118007135-A | Corrosion inhibition method for inhibiting metal corrosion in sulfur-containing medium | 福建理工大学 | 2024-05-10 | — | — | CN | disclosed |
| US-11845724-B2 | USP30 inhibitors and uses thereof | VINCERE BIOSCIENCES, INC. (US) | 2023-12-19 | — | — | US | disclosed |
| EP-3601232-B1 | COMPOSITIONS AND METHODS COMPRISING SUBSTITUTED 2-AMINOIMIDAZOLES | CURZA GLOBAL LLC (US) | 2022-11-23 | — | — | EP | disclosed |
| WO-2022216717-A1 | CITRON KINASE INHIBITORS | THE CLEVELAND CLINIC FOUNDATION (US) | 2022-10-13 | — | — | WO | disclosed |
| US-20220315531-A1 | USP30 INHIBITORS AND USES THEREOF | VINCERE BIOSCIENCES, INC. | 2022-10-06 | — | — | US | disclosed |
| US-4603121-A | ANALGESICS | G. D. SEARLE & CO. (US) | 1986-07-29 | — | — | US | disclosed |
| EP-0136720-A2 | Enkephalin analogs | G.D. Searle & Co. (US) | 1985-04-10 | — | — | EP | disclosed |
| US-4510085-A | Antihypertensive tetrapeptide amides | G.D. SEARLE & CO. (US) | 1985-04-09 | — | — | US | disclosed |
| US-4495178-A | Enkephalin analogs | G. D. SEARLE & CO. (US) | 1985-01-22 | — | — | US | disclosed |
| US-4407746-A | Cyclohexyl and phenyl substituted enkephalins | G. D. SEARLE & CO. (US) | 1983-10-04 | — | — | US | disclosed |
| EP-0081838-A1 | Cyclohexyl and phenyl substituted enkephalins | G.D. Searle & Co. (US) | 1983-06-22 | — | — | EP | disclosed |
| US-4178371-A | ANALGESIC, NARCOTIC ANTAGONIST OR ANTIDIARRHEAL AGENT | RECKITT & COLMAN PRODUCTS LIMITED (GB) | 1979-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250243196-A1 | CITRON KINASE INHIBITORS | CHEK2, CILK1, DCK | MMP13 2733/4885REN 4031/4885ITGB3 3226/4885 |
| US-11845724-B2 | USP30 inhibitors and uses thereof | USP30, USP28, USP1 | MMP13 3472/4885REN 3915/4885ITGB3 4634/4885 |
| US-20220315531-A1 | USP30 INHIBITORS AND USES THEREOF | USP30, USP28, USP1 | MMP13 3472/4885REN 3915/4885ITGB3 4634/4885 |
| US-20240262792-A1 | USP30 INHIBITORS AND USES THEREOF | USP30, USP28, USP1 | MMP13 3472/4885REN 3915/4885ITGB3 4634/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.